Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202052) titled 'Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Monash University
Condition:
Myeloma
Non-Hodgkin's Lymphoma
Leukemia
Intervention:
Biological: Intravenous immunoglobulin
Drug: Trimethoprim / Sulfamethoxazole
Drug: Amoxicillin clavulanic acid
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: May 6, 2025
Target Sample Size: 900
Cou...